Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome

Fertility and Sterility

Volumn 67, Issue 5, 1997, Pages 889-899

  Loumaye, Ernest ^a   Engrand, Patrick ^b   Howles, Colin M ^c   O'Dea, Louis ^d  

^a PregLem Gedeon Richter   (Switzerland)

^b Corporate Biometrics Department ^*  (Switzerland)

^c Ares Scrono Europe   (Switzerland)

^d Serono Inc   (United States)

Author keywords

ART; estradiol; FSH; GnRH agonist; Luteinizing hormone; recombinant FSH

Indexed keywords

BUSERELIN; BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; LEUPRORELIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; ESTROGEN RELEASE; FEMALE; FERTILIZATION IN VITRO; GOOD CLINICAL PRACTICE; HUMAN; HUMAN CELL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY FOLLICLE DEVELOPMENT; PHASE 3 CLINICAL TRIAL; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031000979     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81402-1     Document Type: Article

References (23)

1. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists for in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888-96.
2. FIVNAT (French In Vitro National). Pregnancies and births resulting from in vitro fertilization: French national registry, analysis of data 1986 to 1990. Fertil Steril 1995;64:746-56.
3. Bustillo M. Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 1995;64:13-21.
4. Howles CM, Loumaye E, Giroud D, Luyet G. Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study. Hum Reprod 1994;9:424-30.
5. Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil Steril 1995;64:347-54.
6. Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 1988;66:552-6.
7. Shoham Z, Balen A, Patel A, Jacobs HS. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991;56:1048-53.
8. Schoot DC, Harlin J, Shoham Z, Mannaerts BMJL, Lahlou N, Bouchard P, et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum Reprod 1994;9:1237-42.
9. Balasch J, Miró F, Burzaco I, Casamitjana R, Civico S, Ballescá JL, et al. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from invitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod 1995;10:1678-83.
10. Chappel SC, Howles C. Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6:1206-12.
11. Recombinant FSH Study Group. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril 1995;63:77-86.
12. Steelman SL, Pohley FM. Assay of the FSH based on the augmentation with hCG. Endocrinology 1953;53:604-16.
13. Jaakkola T, Ding Y, Valavaara R, Martikainen H, Tapanainen J, Ronnberg L, et al. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay. J Clin Endocrinol Metab 1990;70:1496-505.
14. Meldrum DR, Tsao Z, Braunstein GD, Sladek J, Lu JK, Rivier J, et al. Stimulation of LH fragments bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab 1984;58:755-7.
15. Millier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-91.
16. Loumaye E. The control of endogenous secretion of LH by gonadotropin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilisation and embryo transfer. Hum Reprod 1990;5:357-76.
17. Marcus SF, Edwards RG. High rates of pregnancy after long-term down-regulation of women with severe endometriosis. Am J Obstet Gynecol 1994;171:812-7.
18. Williams RF, Hodgen GD. Disparate effects of human chorionic gonadotropin during the late follicular phase in monkeys: normal ovulation, follicular atresia, ovarian acyclicity, and hypersecretion of follicle-stimulating hormone. Fertil Steril 1980;33:64-8.
19. Clark L, Stanger J, Brinsmead M. Prolonged follicle stimulation decreases pregnancy rates after in vitro fertilization. Fertil Steril 1991:55:1192-4.
20. Dimitry ES, Oskarsson T, Conanghan J, Margara R, Winston RML. Beneficial effects of a 24 h delay in human chorionic gonadotropin administration during in-vitro fertilization. Hum Reprod 1991;6:944-6.
21. Tan SL, Balen A, Hussein E, Mills C, Campbell S, Yovich J, et al. A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization. Fertil Steril 1992;57:1259-64.
22. Hull M, Corrigan E, Piazzi A, Loumaye E. Recombinant human luteinising hormone: an effective new gonadotropin preparation. Lancet 1994;344:334-5.
23. Kousta E, White DM, Piazzi A, Loumaye E, Franks S. Successful induction of ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome. Hum Reprod 1996;11:70-1.